Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

Name: Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy
Published: 2025
License: Public Domain

University of Virginia · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

glp obesity semaglutide

obesity in children, bone strength, glp - 1, lifestyle modification, bone density, obesity, glp-1, semaglutide, liraglutide, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Bone Metabolism in 12-21 Year Olds Undergoing Glucagon Like Peptide (GLP)-1 Receptor Agonist Therapy

Related documents